top
Search terms
Results 1 - 5 of 5 - ordered by :
Escardio

European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 2, April 2019, Pages 70–79 Dr Camm et al. analysed XANTUS study data and assessed outcomes associated with ...

Date : 01/04/2019
Escardio

Watch the webinar recording Faculty Speakers Professor Giuseppe Rosano, FESC, FHFA St George's Hospital Medical School London, United Kingdom Professor Petar Seferovic, FESC, FHFA Belgrade University ...

Date : 01/03/2019
Escardio

Atherosclerotic cardiovascular disease –ASCVD-, either clinical or unequivocal on imaging (CT scan included in these guidelines); diabetes mellitus with target organ damage, long standing ...

Date : 28/10/2019
Escardio

The Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT) already published and presented during AHA 20181 randomized 8179 patients with established ...

Date : 06/05/2019
Escardio

Clinical trials with GLP-1 receptor agonists and SGLT2-inhibitors clearly indicates that a considerably improved cardioprotection has been made available. [...]the potential to reduce the risk of ...

Date : 09/12/2019